Gonadotropin-releasing hormone: An update review of the antagonists versus agonists
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gonadotropin-releasing hormone: An update review of the antagonists versus agonists
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF UROLOGY
Volume 19, Issue 7, Pages 594-601
Publisher
Wiley
Online
2012-03-15
DOI
10.1111/j.1442-2042.2012.02997.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathways of chemotherapy resistance in castration-resistant prostate cancer
- (2011) K. L. Mahon et al. ENDOCRINE-RELATED CANCER
- Gonadotropin-Releasing Hormone Blockers and Cardiovascular Disease Risk: Analysis of Prospective Clinical Trials of Degarelix
- (2011) Matthew R. Smith et al. JOURNAL OF UROLOGY
- A Phase III Extension Trial With a 1-Arm Crossover From Leuprolide to Degarelix: Comparison of Gonadotropin-Releasing Hormone Agonist and Antagonist Effect on Prostate Cancer
- (2011) E. David Crawford et al. JOURNAL OF UROLOGY
- Degarelix, a novel GnRH antagonist, causes minimal histamine release compared with cetrorelix, abarelix and ganirelix in an ex vivo model of human skin samples
- (2010) Wolfgang Koechling et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- 140 OPEN-LABEL, EXPLORATORY STUDY OF DEGARELIX AS SECOND-LINE HORMONAL THERAPY IN PATIENTS WITH PROSTATE CANCER (CS27)
- (2010) K. Miller et al. EUROPEAN UROLOGY SUPPLEMENTS
- Cardiovascular Safety of Degarelix: Results From a 12-Month, Comparative, Randomized, Open Label, Parallel Group Phase III Trial in Patients With Prostate Cancer
- (2010) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Prostate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients
- (2009) Guo-Wen Lin et al. ASIAN JOURNAL OF ANDROLOGY
- Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study
- (2009) Fritz H. Schröder et al. BJU INTERNATIONAL
- Castration-resistant Prostate Cancer: From New Pathophysiology to New Treatment Targets
- (2009) Kim N. Chi et al. EUROPEAN UROLOGY
- Additional Analysis of the Secondary End Point of Biochemical Recurrence Rate in a Phase 3 Trial (CS21) Comparing Degarelix 80mg Versus Leuprolide in Prostate Cancer Patients Segmented by Baseline Characteristics
- (2009) Bertrand Tombal et al. EUROPEAN UROLOGY
- Prostate-Specific Antigen Progression Predicts Overall Survival in Patients With Metastatic Prostate Cancer: Data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916
- (2009) Maha Hussain et al. JOURNAL OF CLINICAL ONCOLOGY
- The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
- (2008) Laurence Klotz et al. BJU INTERNATIONAL
- Degarelix: A Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker—Results from a 1-yr, Multicentre, Randomised, Phase 2 Dosage-Finding Study in the Treatment of Prostate Cancer
- (2008) Hendrik Van Poppel et al. EUROPEAN UROLOGY
- A 1-Year, Open Label, Randomized Phase II Dose Finding Study of Degarelix for the Treatment of Prostate Cancer in North America
- (2008) Marc Gittelman et al. JOURNAL OF UROLOGY
- Will GnRH antagonists improve prostate cancer treatment?
- (2008) Ilpo Huhtaniemi et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Testosterone Surge: Rationale for Gonadotropin-Releasing Hormone Blockers?
- (2008) Hendrik van Poppel et al. UROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started